Health Equity: How Can Pharma Put the “S” in ESG?

Health Equity: How Can Pharma Put the “S” in ESG?

As COVID-19 has unequally affected many racial and ethnic minority groups, the crisis served as a call to action within the public health community, spurring pharma to pursue actionable efforts toward reversing health inequity. Our media analysis found that the top...
Biotech: Pharma’s Reputation Saviour?

Biotech: Pharma’s Reputation Saviour?

Our recent pharma analysis concluded that journalists have started to report more favourably of pharma’s work and that companies are experiencing a reputational boost as the pandemic highlights their role in developing medications and vaccines. This comes at a time...